Two pathways of carcinogenesis: MSI vs CIN in Iranian patinets with colorectal cancer

被引：0
|
作者：
Molaei, Mahsa [1 ]
Noorinayer, Babak [1 ]
Ghanbarimotlagh, Ali [1 ]
Emami, S. Alireza [1 ]
Ghiasi, Somaye [1 ]
Zali, Mohamadreza [1 ]
机构：
[1] Shahid Beheshti Univ Med Sci, Res Ctr Gastroenterol & Liver Dis, Tehran, Iran
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2007年 / 102卷
关键词：
D O I：
10.14309/00000434-200709002-00387
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
387
引用
收藏
页码：S257 / S258
页数：2
相关论文
共 50 条
  • [31] Targeting two radiation-induced immunosuppressive pathways to improve the efficacy of normofractionated radiation therapy in a preclinical colorectal cancer model
    Boustani, Jihane
    Lecoester, Benoit
    Baude, Jeremy
    Latour, Charlene
    Limagne, Emeric
    Ladjohoulou, Riad
    Morgand, Veronique
    Froidurot, Lisa
    Ghiringhelli, Francois
    Truc, Gilles
    Adotevi, Olivier
    Mirjolet, Celine
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2024, 100 (06) : 912 - 921
  • [32] Study of the aqueous extract of Aloe vera and its two active components on the Wnt/β-catenin and Notch signaling pathways in colorectal cancer cells
    Peng, Chang
    Zhang, WeiJia
    Dai, Cong
    Li, Wa
    Shen, Xue
    Yuan, YueMei
    Yan, Li
    Zhang, Wei
    Yao, MeiCun
    JOURNAL OF ETHNOPHARMACOLOGY, 2019, 243
  • [33] TGF-β Pathways Stratify Colorectal Cancer into Two Subtypes with Distinct Cartilage Oligomeric Matrix Protein (COMP) Expression-Related Characteristics
    Ding, Jia-Tong
    Zhou, Hao-Nan
    Huang, Ying-Feng
    Peng, Jie
    Huang, Hao-Yu
    Yi, Hao
    Zong, Zhen
    Ning, Zhi-Kun
    BIOMOLECULES, 2022, 12 (12)
  • [34] Cost comparison of two treatment regimens for metastatic colorectal cancer.: 5-fluorouracil plus leucovorin vs. capecitabine.
    Arén, O
    Calveira, S
    Banchero, P
    Barnech, A
    Sosa, D
    ANNALS OF ONCOLOGY, 2000, 11 : 56 - 56
  • [35] The earliest events in BRAF-mutant colorectal cancer: exome sequencing of sessile serrated lesions with a tiny focus dysplasia or cancer reveals recurring mutations in two distinct progression pathways
    Bleijenberg, Arne G. C.
    IJspeert, Joep E. G.
    Mulder, Jos B. G.
    Drillenburg, Paul
    Stel, Herbert, V
    Lodder, Elisabeth M.
    Carvalho, Beatriz
    Jansen, Jade
    Meijer, Gerrit
    van Eeden, Susanne
    Dekker, Evelien
    van Noesel, Carel J. M.
    JOURNAL OF PATHOLOGY, 2022, 257 (02): : 239 - 249
  • [36] NRG-GI004/SWOG-S1610: Colorectal Cancer Metastatic dMMR/MSI-H Immunotherapy (COMMIT) Study: A Randomized Phase 3 Study of mFOLFOX6/Bevacizumab/Atezolizumab Combination vs Single Agent Atezolizumab in the First-Line Treatment of Patients With Deficient DNA Mismatch Repair (dMMR)/Microsatellite Instability-High (MSI-H) Metastatic Colorectal Cancer (NCT02997228).
    不详
    ONCOLOGY-NEW YORK, 2021, 35 (06): : 367 - 367
  • [37] Polymorphisms in beta-defensin pathways and clinical outcomes in metastatic colorectal cancer patients treated with FOLFIRI-bevacizumab in two randomized phase III trials.
    Naseem, Madiha
    Berger, Martin D.
    Puccini, Alberto
    Tokunaga, Ryuma
    Battaglin, Francesca
    Barzi, Afsaneh
    Soni, Shivani
    McSkane, Michelle
    Cao, Shu
    Millstein, Joshua
    Zhang, Wu
    Loupakis, Fotios
    Stintzing, Sebastian
    Heinemann, Volker
    Falcone, Alfredo
    Lenz, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [38] Unanticipated pathological clearance in two cases of clinical T4b dMMR/MSI-h advanced colorectal cancer: the potential of immune checkpoint inhibitors despite positive positron-emission tomography results
    Nakamura, Daigaku
    Yanagita, Takeshi
    Fujii, Yoshiaki
    Watanabe, Kaori
    Suzuki, Takuya
    Ushigome, Hajime
    Nishigaki, Ruriko
    Sugimura, Naomi
    Tanaka, Mamoru
    Ogawa, Ryo
    Takahashi, Hiroki
    Shimura, Takaya
    Hotta, Yuji
    Matsuo, Yoichi
    Kondo, Masahiro
    Furukawa-Hibi, Yoko
    Takiguchi, Shuji
    SURGICAL CASE REPORTS, 2024, 10 (01):
  • [39] First results of nivolumab (NIVO) plus ipilimumab (IPI) vs NIVO monotherapy for microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC) from CheckMate 8HW.
    Andre, Thierry
    Elez, Elena
    Lenz, Heinz-Josef
    Jensen, Lars Henrik
    Touchefeu, Yann
    Van Cutsem, Eric
    Garcia-Carbonero, Rocio
    Tougeron, David
    Mendez, Guillermo
    Schenker, Michael
    de la Fouchardiere, Christelle
    Limon, Maria Luisa
    Yoshino, Takayuki
    Li, Jin
    Aubin, Francine
    Cela, Elvis
    Chen, Tian
    Lei, Ming
    Jin, Lixian
    Lonardi, Sara
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : LBA143 - LBA143
  • [40] Clinicopathological factors influencing outcome in metastatic colorectal cancer patients treated with fluoropyrimidine and bevacizumab maintenance treatment vs observation: an individual patient data meta-analysis of two phase 3 trials
    Kaitlyn K H Goey
    Sjoerd G Elias
    Axel Hinke
    Martijn G H van Oijen
    Cornelis J A Punt
    Susanna Hegewisch-Becker
    Dirk Arnold
    Miriam Koopman
    British Journal of Cancer, 2017, 117 : 1768 - 1776
12345